home All News open_in_new Full Article

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

ROCKVILLE, Md. & EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three months ended March 31, 2025. First Quarter 2025 Financial Results Total Revenue: For the three months ended March 31, 2025, total revenue was $62.5 million, up 24% from $50.3 million in the same period of 2024. Net […]


today 7 h. ago attach_file Other

attach_file Sport
attach_file Other
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Economics
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Other
attach_file Culture
attach_file Other
attach_file Culture


ID: 3074779773
Add Watch Country

arrow_drop_down